What is the recommended treatment for primary syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Syphilis Management

Recommended Treatment

Benzathine penicillin G 2.4 million units intramuscularly as a single dose is the definitive treatment for primary syphilis. 1, 2

This regimen has demonstrated 90-100% treatment success rates and represents over 50 years of clinical experience as the gold standard therapy. 3, 4

Essential Concurrent Actions

All patients diagnosed with primary syphilis must be tested for HIV infection immediately. 1, 2

  • HIV coinfection affects follow-up monitoring frequency and may increase risk for neurologic complications 1, 2
  • The same single-dose penicillin regimen is used regardless of HIV status 1

Alternative Treatment for Penicillin Allergy

For documented penicillin allergy in non-pregnant adults, doxycycline 100 mg orally twice daily for 14 days is the preferred alternative. 1, 2, 5

  • Tetracycline 500 mg orally four times daily for 14 days is an option, but compliance is typically worse due to gastrointestinal side effects 2
  • Research demonstrates that doxycycline/tetracycline achieves 100% serological treatment success rates comparable to penicillin 6
  • Pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment—no alternatives are acceptable 1

Follow-Up Protocol

HIV-negative patients require clinical and serologic evaluation at 6 and 12 months using quantitative nontreponemal tests (RPR or VDRL). 3, 2

  • HIV-positive patients require more frequent monitoring at 3,6,9, and 12 months 2
  • Treatment success is defined as a fourfold decline in nontreponemal titer within 6 months 1, 2

Treatment Failure Criteria

Treatment failure should be suspected if any of the following occur: 3, 2

  • Nontreponemal titers fail to decline fourfold within 6 months after therapy
  • Clinical signs or symptoms persist or recur
  • Sustained fourfold increase in titer compared to baseline

When treatment failure is suspected: 7

  • Re-evaluate for HIV infection 7
  • Perform CSF examination to exclude neurosyphilis 3, 7
  • Re-treat with benzathine penicillin G 2.4 million units IM weekly for 3 weeks if CSF is normal 7
  • If CSF shows neurosyphilis, treat with aqueous crystalline penicillin G 18-24 million units daily IV for 10-14 days 7

Partner Management

All sexual contacts from the past 3 months plus duration of symptoms should be evaluated and treated presumptively, even if seronegative. 3, 1

  • Partners should receive the same treatment regimen (benzathine penicillin G 2.4 million units IM single dose) 2

Critical Pitfalls to Avoid

Do not use treponemal tests (FTA-ABS, TP-PA) to monitor treatment response—they remain positive for life and do not correlate with disease activity. 1, 2

Do not switch between different nontreponemal test types (VDRL vs RPR) when monitoring—results cannot be directly compared. 1, 2

Do not assume treatment failure in patients with persistent low-titer reactivity ("serofast" state)—approximately 15-25% of patients remain serofast with low unchanging titers despite cure. 2

Do not use oral penicillin preparations—they are ineffective for syphilis treatment. 1

Jarisch-Herxheimer Reaction

Patients should be informed about the Jarisch-Herxheimer reaction, an acute febrile reaction that may occur within 24 hours after treatment. 1

  • This reaction may include fever, headache, myalgia, and other flu-like symptoms 1
  • It is more common in early syphilis but does not indicate treatment failure 1

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Primary Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Serologic Relapse in Treated Syphilis: Management Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.